コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 ntly low and unchanged, respectively, whereas the attrition was significantly higher (3.6%, P = 0.049) when compared to W
2 ancer, the percentage of patients who were alive at 3 years was significantly higher among those who received darolutamid
3 Susceptibility to a second-line regimen was significantly higher among women, younger individuals, th
5 On POD1, the incidence of IOP spike >40 mmHg was significantly higher at 14.4% in the NMS group compared w
6 The inflammatory response in male intestine was significantly higher compared to females, with a higher i
9 f diabetes mellitus, depression, and cardiovascular disease was significantly higher for THIN cohort in adjusted analyses
13 Specific airway resistance (sR(aw) ) was significantly higher in FE compared with IE trajectory th
14 rcinoma (83%); however, the rate of squamous cell carcinoma was significantly higher in females (35% vs 11%, respectively
15 er in dust from fire stations than from homes, and 8:2 FTOH was significantly higher in homes than in fire stations.
17 the proportion of people living with HIV who were diagnosed was significantly higher in intervention communities (absolut
19 The percentage of eyes receiving 1 injection was significantly higher in naive vs PT DME eyes (76.1 vs 47.
21 % (31 of 44) with vancomycin, whereas the rate of GC at EOS was significantly higher in participants receiving fidaxomici
23 In a multivariate analysis, increased signal intensity was significantly higher in patients with cardiovascular risk
24 overall prevalence of M. genitalium infection was 10.3% and was significantly higher in persons ages 15 to 24 years than
27 However, with CsChrimson, dopamine release was significantly higher in the heel than the medial tip, and
28 -up time of 696 days (interquartile range 1201 d), survival was significantly higher in the non-ECMO group (P = 0.004) bu
29 The proportion of patients with no nausea was significantly higher in the olanzapine group in the acute
30 I 1.54-3.95), and the proportion of participants with SVR12 was significantly higher in the primary care arm, compared to
33 than expected for 22% of procedures, during which workload was significantly higher (P < 0.05) and procedural durations
34 lformations, the incidence of embryo loss and malformations was significantly higher, suggesting a gene-environment inter
35 Survival at 90 days for patients treated with VA-ECMO was significantly higher than for controls (60% vs 25%, risk
36 te canalization was attained in 69% of JOAG patients, which was significantly higher than in PCG patients (22%; P = 0.007
37 The COPD incidence in the lowest airway to lung quartile was significantly higher than in the highest quartile (80.6 v
39 The UPE of the NSC in the sixth subculturing passage was significantly higher than in the primary passage (P < 0.0
40 s commencing treatment in the primary care arm (75%, 43/57) was significantly higher than in the SOC arm (34%, 18/53; P <
43 neurodegenerative diseases (AUC, 0.96 [95% CI, 0.93-0.98]) was significantly higher than plasma P-tau181, plasma NfL, an
44 The partial AUC for the M2M DL algorithm was significantly higher than that for the probability of GON
45 The plaque-to-healthy vessel wall ratio of (68)Ga-FOL was significantly higher than that of (18)F-FDG.
46 urements over a 6-month period (n=89), the AUROC of TREAT-B was significantly higher than that of the simplified WHO crit
47 The incidence rate for women with migraine with aura was significantly higher than the adjusted incidence rate amo
49 rimary prostate cancer; however, the tumor-to-bladder ratio was significantly higher with (18)F-rhPSMA-7 (4.9 +/- 5.3 vs.